Linear α-human atrial natriuretic peptide analogs display receptor binding activity and inhibit α-hANP-induced cGMP accumulation
- 1 November 1989
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 164 (3) , 1295-1301
- https://doi.org/10.1016/0006-291x(89)91810-x
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Identification of structural requirements for analogs of atrial natriuretic peptide (ANP) to discriminate between ANP receptor subtypesJournal of Medicinal Chemistry, 1989
- A membrane form of guanylate cyclase is an atrial natriuretic peptide receptorNature, 1989
- Functional multiplicity of atrial natriuretic peptide receptors on cultured rat Leydig tumor cellsFEBS Letters, 1988
- Physiological Role of Silent Receptors of Atrial Natriuretic FactorScience, 1987
- Atrial Natriuretic Peptide: A New Factor in Blood Pressure ControlJournal Of Hypertension, 1987
- Divergence of ANF analogs in smooth muscle cell cGMP response and aorta vasorelaxation: Evidence for receptor subtypesBiochemical and Biophysical Research Communications, 1987
- Cyclic guanosine monophosphate as a mediator of vasodilation.Journal of Clinical Investigation, 1986
- Molecular forms of atrial natriuretic polypeptides in mammalian tissues and plasmaBiochemical and Biophysical Research Communications, 1985
- Vascular receptor binding activities and cyclic GMP responses by synthetic human and rat atrial natriuretic peptides (ANP) and receptor down-regulation by ANPBiochemical and Biophysical Research Communications, 1985
- Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP)Biochemical and Biophysical Research Communications, 1984